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Abstract: A novel, convenient procedure has been described for the construction of fluorine-
containing benzazepines. The synthetic protocol starting from readily available 
dihydronaphthalene regioisomers is based on oxidative ring olefin bond cleavage followed by 
ring closure of the diformyl intermediates in the presence of some fluorine-containing primary 
amines across double reductive amination. The applicability of the developed synthetic method 
was demonstrated by the Graphical abstract: 
 
synthesis of 13 benzazepine compounds isolated in 22–35% overall yields. 
 






Functionalized azepanes constitute important components of several biologically 
relevant natural and non-natural products with interesting pharmaceutical properties. Some 
representatives of this class of azaheterocycles are known as antiviral agents, glycosidase 
inhibitors, anticancer agents or antidiabetics [1-5]. Therefore, in view of their medicinal 
relevance, an increasing number of synthetic methods have been described in recent years for 
the construction of highly substituted azepane derivatives [6-10]. Fluorine chemistry has 
become a rapidly expanding research area during the last 10–15 years. Because of the high 
impact of organofluorine molecules in drug research (approximately 25% of the drugs 
introduced in the market contain at least one fluorine atom) and agrochemistry, the synthesis of 
fluorinated organic scaffolds has been recognized to be a hot topic in synthetic organic 
chemistry over the past decades [11-13]. This high interest is based on the general 
understanding that the presence of fluorine atom(s) can influence biological property, metabolic 
stability, acid–base character, and lipophilicity [14-20]. Functionalized azepanes are important 
frameworks in small drug molecular design. Accordingly, the incorporation of F atom(s) in 
these seven-membered azaheterocycles has generated increasing interest in pharmaceutical 
research. 
Benzo-fused azepines (benzazepines) including their functionalized derivatives form a 
relevant subclass in the area of azaheterocyclic compounds. Many representatives of these 
compounds, some of them found in various commercial drugs, are known to possess important 
biological properties. The structures of some representative drugs with a benzazepine core are 





Figure 1. Structures of some bioactive benzazepine derivatives. 
 
For example, Lorcaserin (1) [21] is a drug used in the treatment of obesity, Ivabradine 
(2) [15] and Zatebradine (3) [22] are cardioprotective drugs (hyperpolarization-activated cyclic 
nucleotide-gated (HCN) channel blocker), Benazepril (4) [23] is known as angiotensin-
converting enzyme (ACE) inhibitor, Fedovapagon (5) [23] possesses antidiuretic properties, 
while Fenoldopam (Corlopam) (6) [24] is a D1-like receptor agonist (Figure 1). 
Despite the fact that a relatively large number of functionalized azepanes, fluorine-
containing azepines, and various benzazepines with biological properties are known, there are 
only a very limited number of examples of fluorine-containing bioactive benzazepines available 
in the literature. The structure of several representatives of this group of bioactive products is 




Figure 2. Several fluorine-containing benzazepines with biological activities. 
 
Considering the potential biological importance of fluorine-containing benzazepines on the one 
hand and the limited number of literature reports on these scaffolds on the other hand, the 
development of new synthetic strategies towards these structures represents a relevant challenge 
in synthetic organic chemistry. Within that framework, the main objective of this research 
involved the preparation of different types of fluorine-containing benzazepines via a convenient 
new approach. 
 
Results and Discussion 
The synthetic concept towards the construction of benzazepine scaffolds was based on 
our earlier findings regarding the synthesis of functionalized, saturated azaheterocyclic 
substances. This protocol involved the oxidative cleavage of the ring olefin bond of substituted 
cycloalkenes, followed by ring closing of the diformyl intermediates mediated by double 
reductive amination with various primary amines [28-30]. 
Our synthetic strategy for the creation of the benzazepine ring system started with the 
dihydroxylation of the ring C–C double bond of 1,2-dihydronaphthalene (1) with OsO4 (2 
mol%)/NMO in acetone at room temperature, which provided the corresponding cis-diol 
derivative (±)-2 [31]. Vicinal diol (±)-2 was next subjected to oxidative C–C ring cleavage with 
NaIO4 in a THF/H2O solvent system giving an unstable diformyl intermediate (I-1), which was 
then used further without isolation. It is well known that fluorine atoms incorporated into the 
structure of an organic scaffold, especially in the skeleton of an azaheterocycles, will 
significantly affect basic characteristics. Therefore, we intended to carry out the construction 
of the benzazepine skeleton by ring closing of dialdehyde intermediate I-1 using various 
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Scheme 1. Synthesis of benzazepine 3 containing a trifluoromethyl group. 
 
Thus, dialdehyde I-1 resulting from the ring opening of diol (±)-2 was submitted to 
double reductive amination with 2,2,2-trifluoroethylamine hydrochloride in the presence of 
NaHCO3 and reducing agent in CH2Cl2 at room temperature. After investigating various 
reducing agents such as NaBH4, NaBH(OAc)3 and NaBH3CN, while the first two provided the 
desired product in low yields (12% and 18%), the reaction in the presence of the latter reagent, 
after 3 h, yielded the corresponding trifluoromethyl-containing benzazepine 3 in moderate yield 
(55%, two steps) (Scheme 1) confirming the feasibility of the proposed synthetic strategy. 
In continuation, we extended the protocol described above towards the preparation of 
other benzazepines derivatives. Thus, diol (±)-2 was submitted to NaIO4-mediated ring opening 
followed by subsequent treatment of diformyl intermediate I-1 with four different fluorine-
containing primary amines: 2-fluoroethylamine, 2,2-difluoroethylamine, 3,3,3-
trifluoropropylamine, and 1,1,1-trifluoropropan-2-amine. The reductive amination with the 













































Table 1. Synthesized benzazepane derivatives 4–9 from diol (±)-2. 
 
Obviously, this procedure could be applied for the access of non-fluorinated derivatives 
as well. When benzylamine or (R)-methylbenzylamine its methyl-substituted counterpart was 
reacted, the corresponding benzazepines 8 and 9 could be isolated in moderate yields (two steps, 
47% and 55%) (Table 1). 
Next, we intended to further extend the synthetic methodology and increase the number 
of benzazepine derivatives by targeting structural isomers. Accordingly, 1,4-
dihydronaphthalene (10) a regioisomer of 1 was subjected to the same oxidative ring opening. 
First compound 10 under OsO4-mediated dihydroxylation conditions yielded the corresponding 
diol (±)-11,8 which subsequently underwent ring opening upon treatment with NaIO4 to furnish 




































Table 2. Synthesized benzazepane derivatives 13–17 diol (±)-11. 
 
Similar to Scheme 1, dialdehyde I-2 was used in the forthcoming step without isolation. 
Thus on treatment with 2,2,2-trifluoroethylamine in the presence of NaBH3CN, double 
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reductive amination afforded by cyclization the desired benzazepine derivative 12 containing 
the trifluoromethyl group. This product is a regioisomer of 3 (45%, two steps) (Scheme 2). 
Finally, diformyl intermediate I-2 derived from diol 11 was treated with the fluorinated 
primary amines 2-fluoroethylamine, 2,2-difluoroethylamine, 3,3,3-trifluoropropylamine, 1,1,1-
trifluoropropan-2-amine and benzylamine under reductive condition, in the presence of 




In this paper we described a novel route for the construction of 2-benzazepine and 3-
benzazepine ring systems starting from dihydronaphthalene regioisomers, providing a 
convenient access to both tetrahydrobenzo[c]azepine and tetrahydrobenzo[d]azepine 
regioisomers. The key steps of the synthetic procedure are (i) oxidative olefin bond cleavage of 
dihydronaphthalenes followed by (ii) cyclization resulting in a formal ring expansion under 
reductive amination with various primary amines. In view of the importance of organofluorine 
scaffolds, we applied fluorinated amines for the ring-closing step, which yielded various 
fluorine-containing benzazepines. Further extensions of the described procedure regarding the 
access of functionalized benzazepines are currently being studied in our laboratory. 
 
Experimental 
General procedure for dihydroxylation of dihydronaphthalene  
To a solution of 1,2-dihydronaphthalene or 1,4-dihydronaphthalene (2 mmol) in acetone (30 
mL) was added NMO (1.5 equiv) at 0 °C with stirring, followed by addition of a solution of 2% 
OsO4 in t-butyl alcohol (0.3 mL). Next the resulting mixture was stirred for 3 h at room 
temperature. After termination of the reaction (monitored by TLC) 10 mL of saturated aqueous 
Na2SO3 solution was added and the reaction mixture was extracted with CH2Cl2 (3 × 20 mL). 
The combined organic layers were dried over Na2SO4, filtered, and evaporated under reduced 
pressure. The crude product was purified by means of column chromatography on silica gel (n-
hexane/EtOAc or n-hexane/acetone). 
 
General procedure for the synthesis of fluorine-containing benzazepine derivative by 
oxidative ring cleavage followed by ring closure by reductive amination 
To a stirred solution of dihydroxylated tetrahydronaphthalene (2 mmol) NaIO4 (1.5 equiv) was 
added in THF/H2O (25 mL/2 mL). After stirring for 30 min at 20 °C under Ar atmosphere, H2O 
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was added (40 mL). The mixture was then extracted with CH2Cl2 (3 × 20 mL) and the combined 
organic layers were dried over Na2SO4. The resulting solution containing the dialdehyde 
derivative concentrated to half of its volume was used without purification for the next reaction. 
To the solution of the dialdehyde was added fluorine-containing amine hydrochloride (1 equiv) 
and NaHCO3 (2 equiv) or benzylamine or methylbenzylamine (1 equiv, without NaHCO3). 
Then the mixture was stirred at 20 °C for 10 min and, after adding NaBH3CN (1 equiv) and 
AcOH (2 drops), stirring was continued for another 3 h at 20 °C. The reaction mixture was 
diluted with H2O (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (n-hexane/EtOAc or n-hexane/acetone). 
 
Characterization and 1H NMR and 13C NMR spectra of the synthetized compounds are 
available in the Supporting Information 
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